cyproheptadine has been researched along with Rhinitis, Allergic in 8 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
Rhinitis, Allergic: An inflammation of the NASAL MUCOSA triggered by ALLERGENS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rupatadine is a new, second-generation, selective oral H1-antihistamine." | 6.80 | Rupatadine relieves allergic rhinitis: a prospective observational study. ( Eloy, P; Imschoot, J; Tobback, L, 2015) |
| "Rupatadine is a second-generation H1-antihistamine with dual affinity for histamine H1 and PAF receptors." | 6.53 | Rupatadine: global safety evaluation in allergic rhinitis and urticaria. ( Bachert, C; González-Núñez, V; Mullol, J, 2016) |
| " This study aimed to observe the effect of rupatadine fumarate combined with acupoint application in the treatment of allergic rhinitis complicated with diabetes and its effect on serum IgE levels." | 5.72 | Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes. ( Chen, X; Jiang, P; Liu, Y; Shi, J; Zhang, W, 2022) |
| "Rupatadine is a new, second-generation, selective oral H1-antihistamine." | 2.80 | Rupatadine relieves allergic rhinitis: a prospective observational study. ( Eloy, P; Imschoot, J; Tobback, L, 2015) |
| "Rupatadine is a second-generation H1-antihistamine with dual affinity for histamine H1 and PAF receptors." | 2.53 | Rupatadine: global safety evaluation in allergic rhinitis and urticaria. ( Bachert, C; González-Núñez, V; Mullol, J, 2016) |
| " This study aimed to observe the effect of rupatadine fumarate combined with acupoint application in the treatment of allergic rhinitis complicated with diabetes and its effect on serum IgE levels." | 1.72 | Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes. ( Chen, X; Jiang, P; Liu, Y; Shi, J; Zhang, W, 2022) |
| "To optimise a pharmacokinetic (PK) study design of rupatadine for 2-5 year olds by using a population PK model developed with data from a study in 6-11 year olds." | 1.46 | Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children. ( Estévez, JA; Izquierdo, I; Riba, J; Santamaría, E; Valle, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Jiang, P | 1 |
| Chen, X | 1 |
| Zhang, W | 1 |
| Shi, J | 1 |
| Calvão, J | 1 |
| Cardoso, JC | 1 |
| Gonçalo, M | 1 |
| Nieto, A | 2 |
| Nieto, M | 1 |
| Mazón, Á | 1 |
| Santamaría, E | 1 |
| Estévez, JA | 1 |
| Riba, J | 1 |
| Izquierdo, I | 2 |
| Valle, M | 1 |
| Braido, F | 1 |
| Sclifò, F | 1 |
| Ferrando, M | 1 |
| Canonica, GW | 1 |
| Eloy, P | 1 |
| Tobback, L | 1 |
| Imschoot, J | 1 |
| González-Núñez, V | 1 |
| Bachert, C | 1 |
| Mullol, J | 1 |
| Potter, P | 1 |
| Maspero, JF | 1 |
| Vermeulen, J | 1 |
| Barkai, L | 1 |
| Németh, I | 1 |
| Baillieau, RA | 1 |
| Garde, JM | 1 |
| Giralt, J | 1 |
| Doménech, A | 1 |
3 reviews available for cyproheptadine and Rhinitis, Allergic
| Article | Year |
|---|---|
The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine.
Topics: Adult; Child; Child, Preschool; Cyproheptadine; Histamine H1 Antagonists; Humans; Rhinitis, Allergic | 2021 |
New therapies for allergic rhinitis.
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibo | 2014 |
Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
Topics: Animals; Anti-Allergic Agents; Blood-Brain Barrier; Cyproheptadine; Histamine H1 Antagonists; Humans | 2016 |
2 trials available for cyproheptadine and Rhinitis, Allergic
| Article | Year |
|---|---|
Rupatadine relieves allergic rhinitis: a prospective observational study.
Topics: Adult; Cyproheptadine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Prospective Stu | 2015 |
Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Analysis of Variance; Anti-Allergic Agents; Argentina; Child; Cyproheptadine; | 2013 |
3 other studies available for cyproheptadine and Rhinitis, Allergic
| Article | Year |
|---|---|
Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes.
Topics: Acupuncture Points; Cyproheptadine; Diabetes Mellitus; Fumarates; Humans; Immunoglobulin E; Rhinitis | 2022 |
Fixed drug eruption to rupatadine with positive patch tests on non-lesional skin.
Topics: Cyproheptadine; Drug Eruptions; Histamine H1 Antagonists; Humans; Male; Middle Aged; Patch Tests; Re | 2020 |
Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children.
Topics: Algorithms; Anti-Allergic Agents; Child; Child, Preschool; Computer Simulation; Cyproheptadine; Fema | 2017 |